These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2111744

  • 1. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.
    Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E.
    Circulation; 1990 Jun; 81(6):1974-80. PubMed ID: 2111744
    [Abstract] [Full Text] [Related]

  • 2. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro.
    Runge MS, Bode C, Matsueda GR, Haber E.
    Biochemistry; 1988 Feb 23; 27(4):1153-7. PubMed ID: 3130094
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D.
    Eur J Biochem; 1992 Apr 01; 205(1):139-46. PubMed ID: 1313361
    [Abstract] [Full Text] [Related]

  • 4. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D.
    Thromb Haemost; 1992 Aug 03; 68(2):170-9. PubMed ID: 1412163
    [Abstract] [Full Text] [Related]

  • 5. Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrin.
    Bode C, Runge MS, Newell JB, Matsueda GR, Haber E.
    J Biol Chem; 1987 Aug 05; 262(22):10819-23. PubMed ID: 3611093
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J, Yu M, Ru B.
    Biochim Biophys Acta; 2001 Apr 07; 1546(2):399-405. PubMed ID: 11295444
    [Abstract] [Full Text] [Related]

  • 7. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N.
    Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727
    [Abstract] [Full Text] [Related]

  • 8. Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugate.
    Bode C, Runge MS, Newell JB, Matsueda GR, Haber E.
    J Mol Cell Cardiol; 1987 Apr 03; 19(4):335-41. PubMed ID: 3612817
    [Abstract] [Full Text] [Related]

  • 9. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D, Lu HR, Lijnen HR, Nelles L, Stassen JM.
    Circulation; 1991 Sep 03; 84(3):1216-34. PubMed ID: 1909220
    [Abstract] [Full Text] [Related]

  • 10. Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activator.
    Stump DC, Stassen JM, Demarsin E, Collen D.
    Blood; 1987 Feb 03; 69(2):592-6. PubMed ID: 3099862
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D, Lijnen HR, Piérard L, de Foresta F, Demarsin E, Jacobs P, De Wilde M, Bollen A, Collen D.
    J Biol Chem; 1987 Aug 25; 262(24):11779-84. PubMed ID: 3114253
    [Abstract] [Full Text] [Related]

  • 12. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET, Mack DL, Sobel BE.
    Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679
    [Abstract] [Full Text] [Related]

  • 13. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

  • 14. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y, Scully MF, Ellis V, Kakkar VV.
    Thromb Haemost; 1989 Jun 30; 61(3):502-6. PubMed ID: 2508259
    [Abstract] [Full Text] [Related]

  • 15. Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.
    Bode C, Meinhardt G, Runge MS, Freitag M, Nordt T, Arens M, Newell JB, Kübler W, Haber E.
    Circulation; 1991 Aug 30; 84(2):805-13. PubMed ID: 1860223
    [Abstract] [Full Text] [Related]

  • 16. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M, Nguyen G, Desnoyers P, Lourenco DM, Fretault J, Horellou MH, Conard J, Szwarcer E, Verdy E, Vahanian A.
    Fundam Clin Pharmacol; 1988 Aug 30; 2(6):509-23. PubMed ID: 3149257
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 18. Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.
    Collen D, Dewerchin M, Rapold HJ, Lijnen HR, Stassen JM.
    Circulation; 1990 Nov 15; 82(5):1744-53. PubMed ID: 2121385
    [Abstract] [Full Text] [Related]

  • 19. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM, Lin PH, Traylor M, Bruce R.
    J Biol Chem; 1988 Oct 15; 263(29):15139-45. PubMed ID: 3170576
    [Abstract] [Full Text] [Related]

  • 20. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V, Pannell R.
    Thromb Haemost; 1987 Jun 03; 57(3):372-3. PubMed ID: 3116707
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.